Medivation Gets Hostile After Sanofi's "Misleading" Maneuvers

The biotech continues to reject offers from the French pharma and lays out the problems it has with the offer to shareholders. Meanwhile, Sanofi has taken its bid hostile and pushes to replace the biotech's board.